An evidence-based approach to the treatment of Graves' ophthalmopathy

Endocrinology and Metabolism Clinics of North America

Volumn 29, Issue 2, 2000, Pages 297-319

  Wiersinga, Wilmar M ^b   Prummel, Mark F ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; AZATHIOPRINE; CIAMEXON; CYCLOSPORIN; DIURETIC AGENT; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; IODINE 131; METHOTREXATE; METHYLCELLULOSE; OCTREOTIDE; PREDNISONE; THIAMAZOLE; THYROXINE;

ACUPUNCTURE; CLINICAL TRIAL; DECOMPRESSION SURGERY; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE DURATION; EVIDENCE BASED MEDICINE; EYE DISEASE; GRAVES DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PLASMAPHERESIS; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; REVIEW; SMOKING; THYROIDECTOMY; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0034083162     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(05)70133-X     Document Type: Article

References (61)

1. R.S. Bahn C.A. Gorman Choice of therapy and criteria for assessing treatment outcome in thyroid-associated ophthalmopathy Endocrinol Metab Clin North Am 16 1987 391 407
2. L. Bartalena C. Marcocci F. Bogazzi Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism N Engl J Med 321 1989 1349 1352
3. L. Bartalena C. Marcocci F. Bogazzi Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy N Engl J Med 338 1998 73 78
4. L. Bartalena C. Marcocci M.L. Tanda Cigarette smoking and treatment outcomes in Graves' ophthalmopathy Ann Intern Med 129 1998 632 635
5. G.B. Bartley V. Fatourechi E.F. Kadrmas The incidence of Graves' ophthalmopathy in Olmsted County, Minnesota Am J Ophthalmol 120 1995 511 517
6. L. Baschieri A. Antonelli S. Nardi Intravenous immunoglobulin versus corticosteroid in treatment of Graves' ophthalmopathy Thyroid 7 1997 579 585
7. L.E.C.M. Blank I.W. Barendsen M.F. Prummel Probable risk of tumor induction after retro-orbital irradiation for Graves' ophthalmopathy Radiother Oncol 40 1996 185 189
8. R.W. Brain Exophthalmic ophthalmoplegia Q J Med 31 1938 293 323
9. R. Brain Cortisone in exophthalmos: Report on a therapeutic trial of cortisone and corticotrophin (ACTH) in exophthalmos and exophthalmic ophthalmoplegia by a panel appointed by the Medical Research Council Lancet I 1955 6 9
10. H. Burch L. Wartofsky Graves' ophthalmopathy: Current concepts regarding pathogenesis and management Endocr Rev 14 1993 747 793
11. S.S. Donaldson M.A. Bagshaw J.P. Kriss Supervoltage orbital radiotherapy for Graves' ophthalmopathy J Clin Endocrinol Metab 37 1973 276 285
12. M.N. Gerding M.F. Prummel R. Kalmann Colour slides are useful in assessing changes in soft-tissue involvement in Graves' ophthalmopathy J Endocrinol Invest 21 1998 459 462
13. M.N. Gerding F.M. Zant van der E.A. van Royen Octreotide scintigraphy is a disease-activity parameter in Graves' ophthalmopathy Clin Endocrinol 50 1999 373 379
14. Gerding MN, Prummel MF, Wiersinga WM: Assessment of disease activity in Graves' ophthalmopathy by orbital ultrasonography and clinical parameters. Clin Endocrinol, in press
15. D. Glinoer J. Etienne-Decerf M. Schrooyen Beneficial effects of intensive plasma exchange followed by immunosuppressive therapy in severe Graves' ophthalmopathy Acta Endocrinol 111 1986 30 38
16. C.A. Gorman Clever is not enough: NO SPECS is form in search of function Thyroid 1 1991 353 355
17. C.A. Gorman Radioiodine therapy does not aggravate Graves' ophthalmopathy J Clin Endocrinol Metab 80 1995 340 341
18. G. Kahaly J. Schrezenmeir U. Krause Cyclosporin and prednisone vs prednisone in treatment of Graves' ophthalmopathy: A controlled, randomized and prospective study Eur J Clin Invest 16 1986 415 422
19. G. Kahaly W. Lieb W. Muller-Forell Ciamexone in endocrine orbitopathy Acta Endocrinol 122 1990 13 21
20. G. Kahaly S. Pitz W. Müller-Forell Randomized trial of intravenous immunoglobulins versus prednisone in Graves' ophthalmopathy Clin Exp Immunol 106 1996 197 202
21. D.L. Kendler J. Lippa J. Rootman The initial characteristics of Graves' orbitopathy vary with age and sex Arch Ophthalmol 111 1993 197 201
22. J.L. Kinyoun R.E. Kalina S.A. Brower Radiation retinopathy after orbital irradiation for Graves' ophthalmopathy Arch Ophthalmol 102 1984 1473 1476
23. G.E. Krassas A. Dumas N. Pontikides Somatostatin receptor scintigraphy and octreotide treatment in patients with thyroid eye disease Clin Endocrinol 42 1995 571 580
24. G.E. Krassas T.H. Kaltsas A. Dumas Lanreotide in the treatment of patients with thyroid eye disease Eur J Endocrinol 136 1997 416 422
25. A.W.C. Kung C.C. Yau A. Cheng The incidence of ophthalmopathy after radioiodine therapy for Graves' disease: Prognostic factors and the role of methimazole J Clin Endocrinol Metab 79 1994 542 546
26. A.W.C. Kung J. Michon K.S. Tai The effect of somatostatin versus corticosteroid in the treatment of Graves' ophthalmopathy Thyroid 6 1996 381 384
27. C. Marcocci L. Bartalena M. Panicucci Orbital cobalt irradiation combined with retrobulbar or systemic corticosteroids for Graves' ophthalmopathy: A comparative study Clin Endocrinol 27 1987 33 42
28. C. Marcocci L. Bartalena F. Bogazzi Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: Results of a prospective randomized study J Endocrinol Invest 14 1991 853 860
29. C. Marcocci M.L. Tanda L. Manetti Intravenous and oral glucocorticoid therapy in patients with severe Graves' ophthalmopathy: Results of a randomized, single-blind, prospective study [abstract 207] J Endocrinol Invest 22 suppl 6 1999 104
30. C. Marcocci G. Bruno-Bossio L. Manetti The course of Graves' ophthalmopathy is not influenced by near-total thyroidectomy: A case-control study Clin Endocrinol 51 1999 503 508
31. M.L. Miller S.H. Goldberg J.D. Bullock Radiation retinopathy after standard radiotherapy for thyroid-related ophthalmopathy Am J Ophthalmol 112 1991 600 601
32. M.P.H. Mourits M.F. Prummel W.M. Wiersinga Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy Clin Endocrinol 47 1997 9 14
33. H.C. Naffziger Pathologic changes in the orbit in progressive exophthalmos Arch Ophthalmol 9 1933 1 12
34. H. Nakahara S. Noguchi N. Murakami Graves' ophthalmopathy: MR evaluation of 10-Gy versus 24-Gy irradiation combined with systemic corticosteroids Radiology 196 1995 857 862
35. P. Perros D.R. Weightman A.L. Crombie Azathioprine in the treatment of thyroid-associated ophthalmopathy Acta Endocrinol 122 1990 8 12
36. P. Perros A.L. Cromble J.N.S. Matthews Age and gender influence the severity of thyroid-associated ophthalmopathy: A study of 101 patients attending a combined thyroid-eye clinic Clin Endocrinol 38 1993 367 372
37. P. Perros A.L. Crombie P. Kendall-Taylor Natural history of thyroid associated ophthalmopathy Clin Endocrinol 42 1995 45 50
38. A. Pinchera W.M. Wiersinga D. Glinoer Classification of eye changes of Graves' disease Thyroid 2 1992 235 236
39. B.C.P. Polak R. Wijngaarde Radiation retinopathy in patients with both diabetes mellitus and ophthalmic Graves' disease Orbit 141 1995 71 74
40. M.F. Prummel W.M. Wiersinga MPh Mourits Amelioration of eye changes of Graves' ophthalmopathy by achieving euthyroidism Acta Endocrinol 121 suppl 2 1989 185 189
41. M.F. Prummel MPh Mourits A. Berghout Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy N Engl J Med 321 1989 1353 1359
42. M.F. Prummel W.M. Wiersinga MPh Mourits Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy Arch Intern Med 150 1990 1098 1101
43. M.F. Prummel W.M. Wiersinga Smoking and risk of Graves' disease JAMA 269 1993 479 482
44. M.F. Prummel MPh Mourits L. Blank Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy Lancet 342 1993 949 954
45. M.F. Prummel A.E. Heufelder MPh Mourits Recent Developments in Graves' Ophthalmopathy 2000 Kluwer Academic Publishers Boston
46. B.A. Rogvi-Hansen H. Perrild T. Christensen Acupuncture in the treatment of Graves' ophthalmopathy: A blinded randomized study Acta Endocrinol 124 1992 143 145
47. F.F. Rundle Development and course of exophthalmos and ophthalmoplegia in Graves' disease with special reference to the effect of thyroidectomy Clin Sci 5 1945 177 194
48. F.F. Rundle Ocular changes in Graves' disease Q J Med 29 1960 113 126
49. D.L. Sackett W.M.C. Rosenberg J.A.M. Gray Evidence based medicine: What it is and what it isn't BMJ 312 1996 71 72
50. A. Snijders-Keilholz R.J.W. Keizer de B.M. Goslings Probably risk of tumour induction after retro-bulbar irradiation for Graves' ophthalmopathy Radiother Oncol 38 1996 69 71
51. V. Sridama L.J. DeGroot Treatment of Graves' disease and the course of ophthalmopathy Am J Med 87 1989 70 73
52. L. Tallstedt R. Norberg Immunohistochemical staining of normal and Graves' extraocular muscle Invest Ophthalmol Vis Sci 29 1988 175 184
53. L. Tallstedt G. Lundell O. Toørring Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism N Engl J Med 326 1992 1733 1738
54. L. Tallstedt G. Lundell H. Blomgren Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment? Eur J Endocrinol 130 1994 494 497
55. C.B. Terwee M.N. Gerding F.W. Dekker Development of a disease-specific quality-of-life questionnaire for patients with Graves' ophthalmopathy: The GO-QOL Br J Ophthalmol 82 1998 773 779
56. O. Törring L. Tallstedt G. Wallin Graves' hyperthyroidism: Treatment with antithyroid drugs, surgery, or radioiodine—prospective, randomized study J Clin Endocrinol Metab 81 1996 2886 2993
57. A.P. Weetman W.M. Wiersinga Current management of thyroid-associated ophthalmopathy in Europe: Results of an international survey Clin Endocrinol 49 1998 21 28
58. W.M. Wiersinga M.F. Prummel MPh Mourits Classification of eye changes in Graves' disease Thyroid 1 1991 357 360
59. W.M. Wiersinga Advances in medical therapy of thyroid-associated ophthalmopathy Orbit 15 1996 177 186
60. W.M. Wiersinga Preventing Graves' ophthalmopathy N Engl J Med 338 1998 121 122
61. B. Winsa J. Rastad G. Akerström Retrospective evaluation of subtotal and total thyroidectomy in Graves' disease with and without endocrine ophthalmopathy Eur J Endocrinol 132 1995 406 412